ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CNBI China BCT Pharmacy Group Inc (CE)

0.0001
0.00 (0.00%)
23 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
China BCT Pharmacy Group Inc (CE) USOTC:CNBI OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0001 0.00 01:00:00

Certification of No Change in Definitive Materials. (497j)

02/04/2013 2:49pm

Edgar (US Regulatory)



 
U.S. BANCORP FUND SERVICES, LLC
615 East Michigan Street
Milwaukee, WI  53202


April 2, 2013

VIA EDGAR TRANSMISSION

United States Securities and Exchange Commission
Division of Investment Management
100 “F” Street, N.E.
Washington, D.C. 20549
 
RE:
TRUST FOR PROFESSIONAL MANAGERS (the “TRUST”)
Securities Act Registration No: 333-62298
Investment Company Registration No: 811-10401
Gerstein Fisher Multi-Factor Growth Equity Fund (S000026998)
Gerstein Fisher Multi-Factor International Growth Equity Fund (S000035301)
Gerstein Fisher Multi-Factor Global Real Estate Securities Fund (S000040211)
 
Dear Sir or Madam:

Pursuant to Rule 497(j) under the Securities Act of 1933 (the “1933 Act”), as amended, and pursuant to the Investment Company Act of 1940, as amended, and the regulations thereunder, the Trust on behalf of its series, the Gerstein Fisher Multi-Factor Growth Equity Fund, the Gerstein Fisher Multi-Factor International Growth Equity Fund and the Gerstein Fisher Multi-Factor Global Real Estate Securities Fund  (the “Funds”), hereby certifies that the form of Prospectus and Statement of Additional Information that would have been filed under Rule 497(b) or (c) under the 1933 Act would not have differed from that contained in the most recent amendment for the Fund dated March 28, 2013, and filed electronically as Post-Effective Amendment No. 366 to the Fund’s Registration Statement on Form N-1A on March 25, 2013.

If you have any questions regarding the enclosed, please do not hesitate to contact the undersigned at (414) 765-5384.


Very truly yours,

/s/ Rachel A. Spearo                                            

Rachel A. Spearo, Esq.
For U.S. Bancorp Fund Services, LLC

Enclosures
 

1 Year China BCT Pharmacy (CE) Chart

1 Year China BCT Pharmacy (CE) Chart

1 Month China BCT Pharmacy (CE) Chart

1 Month China BCT Pharmacy (CE) Chart